Clinical trials recruiting in Ibadan, Nigeria

Phase breakdown

Conditions recruiting in Ibadan, Nigeria

Recruiting trials in Ibadan, Nigeria

• A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke
  NCT05953584 · Phase: Phase 2 · Ages: 12 Years to 16 Years · Sex: All (male and female)
• A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
  NCT05431088 · Phase: Phase 2, Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female)
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
  NCT06348134 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female
• Change My Story Task Shifted Mental Health Intervention
  NCT06389565 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 29 Years · Sex: All (male and female)
• Combination Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria
  NCT06190613 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 29 Years · Sex: Male
• Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria
  NCT06751030 · Phase: Not specified · Ages: 25 Years to 50 Years · Sex: Female
• Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
  NCT05069688 · Phase: Phase 1 · Ages: 4 Weeks to 5 Years · Sex: All (male and female)
• Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
  NCT06281834 · Phase: Phase 1 · Ages: 4 Weeks to 11 Years · Sex: All (male and female)
• MicroRNA Profiles in Triple Negative Breast Cancer
  NCT04771871 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female
• Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)
  NCT05580666 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
  NCT05561842 · Phase: Not specified · Ages: 18 Years and older · Sex: Female
• The Ibadan Acute and Chronic Heart Failure Project
  NCT05936957 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
  NCT06291064 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female

Common questions

How many clinical trials are recruiting in Ibadan, Nigeria?

15 recruiting trials have at least one study site in Ibadan, Nigeria.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.